FAMILIAL AGGREGATION OF MALIGNANT LYMPHOMAS

Download full text PDF
Issue: 
11
Year: 
2015

D. Zvyagintseva (1); T. Semiglazova (1,3), MD; L. Filatova (1), MD; D. Kurochkina (1); A. Artemyeva (1); S. Kuleva (1,2), MD 1 -N.N. Petrov Research Institute of Oncology, Saint Petersburg 2 -Saint Petersburg State Pediatric Medical University 3 -I.I. Mechnikov North-Western State Medical University, Saint Petersburg

Familial aggregation of malignant lymphomas is encountered rather commonly – only in 0.7–3.0% of cases. The incidence of non-Hodgkin lymphoma and Hodgkin lymphoma in one family (in parent-child and brother-sister pairs) is highest. In this case, the disease is generally characterized by the aggressive course and more frequent occurrence of the lymphomas in younger infants than in their parents. The paper describes cases of aggregation of familial lymphomas in the patients who have been treated at the N.N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation.
Keywords: 
familial aggregation of malignant lymphomas
Hodgkin lymphoma
non-Hodgkin lymphomas

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Beljaev A.M., Merabishvili V.M. Zlokachestvennye novoobrazovanija v Severo-Zapadnom federal'nom okruge. 2-j vyp. / SPb, 2015.
  2. Imjanitov E.N., Hanson K.P. Epidemiologija i biologija nehodzhkinskih limfom // Prakticheskaja onkologija. – 2004; 5 (3): 163.
  3. Bobyntseva O.V., Boldinova E.O., Ivanov V.P. i dr. Analiz urovnja spontannogo mutagenezana raznyh stadijah zlokachestvennyh limfom // Applied and fundamental research. – 2015; 1: 76–9.
  4. de Haan L., Loves S., Daenen S. Familial Aggregation of Non-Hodgkin’s Lymphoma (NHL) // A Case Report, Hereditary Cancer in Clinical Practice. – 2006; 4 (3): 136–9.
  5. Adler B., Barchana M., Ben Yehuda D. et al. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma // Cancer. – 2000; 88: 2357–66.
  6. Adami H., Chang E., Glimelius B. et al. Family History of Hematopoietic Malignancy and Risk of Lymphoma // J. National Cancer Institute. – 2005; 97 (19).
  7. Dancey J., Cheson B., Chiu B. et al. Update on epidemiology and therapeutics for non-Hodgkin’s lymphoma // Hematology (Am. Soc. Hematol. Educ. Program). – 2002; 241 (62).
  8. Harris N., Jaffe E., Stein H. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. WHO Classification of Tumours, Vol. 3 IARC WHO Classification of Tumours. – 2001; 3: 351.
  9. Kari V., Nambiar M., Raghavan S. Chromosomal translocations in cancer // Biochim. Biophys. Acta. – 2008; 2: 139–52.
  10. Gail M., Goldin L., Gridley G. et al. Familial Aggregation of Hodgkin Lymphoma and Related Tumors // Cancer. – 2004; 100 (9): 1902–8.
  11. Czene K., Hemminki K., Li X. Familial risk of cancer: data for clinical counseling and cancer genetics // Cancer. – 2004; 108: 109–14.
  12. Carrington M., Goldstein A., Harty L. et al. HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease // Blood. – 2002; 99: 690–3.
  13. Hemminki K., Czene K.. Attributable risks of familial cancer from the Family- Cancer Database // Cancer Epidemiol. Biomarkers Prev. – 2002; 11: 1638–44.
  14. Cfan W., Rosenvald A., Wright G. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma // N. Engl. J. Med. – 2002; 364: 1937–47.
  15. Armitage J., Alizadeh A., Chan W. et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile // Blood. – 2002; 99: 2285–90.